Value-Based Pharmaceutical Contracts: Value for Whom?
Value Health
; 23(2): 154-156, 2020 02.
Article
em En
| MEDLINE
| ID: mdl-32113619
ABSTRACT
Value-based pharmaceutical contracts (VBPCs) are performance-based reimbursement agreements between healthcare payers and pharmaceutical manufacturers in which the price, amount, or nature of reimbursement is tied to value-based outcomes. VBPCs are often complex, and the nature of who benefits and in what ways can be unclear. We discuss how VBPCs compare with value-based payer-provider arrangements in terms of performance-based reimbursements and alignment of incentives. In addition, we examine how VBPCs can affect costs, clinical outcomes, and access to medications. Because these contracts are unlikely to reduce costs in isolation, we recommend taking a patient-centered approach when developing VBPCs and tying VBPCs to more overarching payer drug cost reduction strategies.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Alocação de Recursos para a Atenção à Saúde
/
Custos de Medicamentos
/
Contratos
/
Indústria Farmacêutica
/
Aquisição Baseada em Valor
/
Seguro de Saúde Baseado em Valor
/
Reembolso de Seguro de Saúde
Limite:
Humans
Idioma:
En
Revista:
Value Health
Assunto da revista:
FARMACOLOGIA
Ano de publicação:
2020
Tipo de documento:
Article